Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
UNICANCER
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Ludwig Institute for Cancer Research